The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dengue Vaccines Market Research Report 2024
Synopsis
Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.
The global Dengue Vaccines market was valued at US$ 400.6 million in 2023 and is anticipated to reach US$ 1033.7 million by 2030, witnessing a CAGR of 14.3% during the forecast period 2024-2030.
The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.
This report aims to provide a comprehensive presentation of the global market for Dengue Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dengue Vaccines.
Report Scope
The Dengue Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dengue Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dengue Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Takeda
Segment by Type
Dengvaxia
TAK-003
Others
Segment by Application
Public Sector
Private Sector
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dengue Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.
The global Dengue Vaccines market was valued at US$ 400.6 million in 2023 and is anticipated to reach US$ 1033.7 million by 2030, witnessing a CAGR of 14.3% during the forecast period 2024-2030.
The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.
This report aims to provide a comprehensive presentation of the global market for Dengue Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dengue Vaccines.
Report Scope
The Dengue Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dengue Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dengue Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Takeda
Segment by Type
Dengvaxia
TAK-003
Others
Segment by Application
Public Sector
Private Sector
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dengue Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dengue Vaccines Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Dengvaxia
1.2.3 TAK-003
1.2.4 Others
1.3 Market by Application
1.3.1 Global Dengue Vaccines Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Public Sector
1.3.3 Private Sector
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dengue Vaccines Market Perspective (2019-2030)
2.2 Dengue Vaccines Growth Trends by Region
2.2.1 Global Dengue Vaccines Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Dengue Vaccines Historic Market Size by Region (2019-2024)
2.2.3 Dengue Vaccines Forecasted Market Size by Region (2025-2030)
2.3 Dengue Vaccines Market Dynamics
2.3.1 Dengue Vaccines Industry Trends
2.3.2 Dengue Vaccines Market Drivers
2.3.3 Dengue Vaccines Market Challenges
2.3.4 Dengue Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dengue Vaccines Players by Revenue
3.1.1 Global Top Dengue Vaccines Players by Revenue (2019-2024)
3.1.2 Global Dengue Vaccines Revenue Market Share by Players (2019-2024)
3.2 Global Dengue Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dengue Vaccines Revenue
3.4 Global Dengue Vaccines Market Concentration Ratio
3.4.1 Global Dengue Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dengue Vaccines Revenue in 2023
3.5 Dengue Vaccines Key Players Head office and Area Served
3.6 Key Players Dengue Vaccines Product Solution and Service
3.7 Date of Enter into Dengue Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dengue Vaccines Breakdown Data by Type
4.1 Global Dengue Vaccines Historic Market Size by Type (2019-2024)
4.2 Global Dengue Vaccines Forecasted Market Size by Type (2025-2030)
5 Dengue Vaccines Breakdown Data by Application
5.1 Global Dengue Vaccines Historic Market Size by Application (2019-2024)
5.2 Global Dengue Vaccines Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Dengue Vaccines Market Size (2019-2030)
6.2 North America Dengue Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Dengue Vaccines Market Size by Country (2019-2024)
6.4 North America Dengue Vaccines Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dengue Vaccines Market Size (2019-2030)
7.2 Europe Dengue Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Dengue Vaccines Market Size by Country (2019-2024)
7.4 Europe Dengue Vaccines Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dengue Vaccines Market Size (2019-2030)
8.2 Asia-Pacific Dengue Vaccines Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Dengue Vaccines Market Size by Region (2019-2024)
8.4 Asia-Pacific Dengue Vaccines Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dengue Vaccines Market Size (2019-2030)
9.2 Latin America Dengue Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Dengue Vaccines Market Size by Country (2019-2024)
9.4 Latin America Dengue Vaccines Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dengue Vaccines Market Size (2019-2030)
10.2 Middle East & Africa Dengue Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Dengue Vaccines Market Size by Country (2019-2024)
10.4 Middle East & Africa Dengue Vaccines Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Dengue Vaccines Introduction
11.1.4 Sanofi Revenue in Dengue Vaccines Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Takeda
11.2.1 Takeda Company Detail
11.2.2 Takeda Business Overview
11.2.3 Takeda Dengue Vaccines Introduction
11.2.4 Takeda Revenue in Dengue Vaccines Business (2019-2024)
11.2.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Dengue Vaccines Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Dengvaxia
Table 3. Key Players of TAK-003
Table 4. Key Players of Others
Table 5. Global Dengue Vaccines Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Dengue Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Dengue Vaccines Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Dengue Vaccines Market Share by Region (2019-2024)
Table 9. Global Dengue Vaccines Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Dengue Vaccines Market Share by Region (2025-2030)
Table 11. Dengue Vaccines Market Trends
Table 12. Dengue Vaccines Market Drivers
Table 13. Dengue Vaccines Market Challenges
Table 14. Dengue Vaccines Market Restraints
Table 15. Global Dengue Vaccines Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Dengue Vaccines Market Share by Players (2019-2024)
Table 17. Global Top Dengue Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dengue Vaccines as of 2023)
Table 18. Ranking of Global Top Dengue Vaccines Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Dengue Vaccines Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dengue Vaccines Product Solution and Service
Table 22. Date of Enter into Dengue Vaccines Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dengue Vaccines Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Dengue Vaccines Revenue Market Share by Type (2019-2024)
Table 26. Global Dengue Vaccines Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Dengue Vaccines Revenue Market Share by Type (2025-2030)
Table 28. Global Dengue Vaccines Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Dengue Vaccines Revenue Market Share by Application (2019-2024)
Table 30. Global Dengue Vaccines Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Dengue Vaccines Revenue Market Share by Application (2025-2030)
Table 32. North America Dengue Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Dengue Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Dengue Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Dengue Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Dengue Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Dengue Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Dengue Vaccines Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Dengue Vaccines Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Dengue Vaccines Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Dengue Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Dengue Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Dengue Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Dengue Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Dengue Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Dengue Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 47. Sanofi Company Detail
Table 48. Sanofi Business Overview
Table 49. Sanofi Dengue Vaccines Product
Table 50. Sanofi Revenue in Dengue Vaccines Business (2019-2024) & (US$ Million)
Table 51. Sanofi Recent Development
Table 52. Takeda Company Detail
Table 53. Takeda Business Overview
Table 54. Takeda Dengue Vaccines Product
Table 55. Takeda Revenue in Dengue Vaccines Business (2019-2024) & (US$ Million)
Table 56. Takeda Recent Development
Table 57. Research Programs/Design for This Report
Table 58. Key Data Information from Secondary Sources
Table 59. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dengue Vaccines Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Dengue Vaccines Market Share by Type: 2023 VS 2030
Figure 3. Dengvaxia Features
Figure 4. TAK-003 Features
Figure 5. Others Features
Figure 6. Global Dengue Vaccines Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Dengue Vaccines Market Share by Application: 2023 VS 2030
Figure 8. Public Sector Case Studies
Figure 9. Private Sector Case Studies
Figure 10. Dengue Vaccines Report Years Considered
Figure 11. Global Dengue Vaccines Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Dengue Vaccines Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Dengue Vaccines Market Share by Region: 2023 VS 2030
Figure 14. Global Dengue Vaccines Market Share by Players in 2023
Figure 15. Global Top Dengue Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dengue Vaccines as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Dengue Vaccines Revenue in 2023
Figure 17. North America Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Dengue Vaccines Market Share by Country (2019-2030)
Figure 19. United States Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Dengue Vaccines Market Share by Country (2019-2030)
Figure 23. Germany Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Dengue Vaccines Market Share by Region (2019-2030)
Figure 31. China Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Dengue Vaccines Market Share by Country (2019-2030)
Figure 39. Mexico Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Dengue Vaccines Market Share by Country (2019-2030)
Figure 43. Turkey Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Dengue Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Sanofi Revenue Growth Rate in Dengue Vaccines Business (2019-2024)
Figure 46. Takeda Revenue Growth Rate in Dengue Vaccines Business (2019-2024)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
